Lilly-Innovent's Sintilimab Plus Chemo Application For Lung Cancer Under Review With FDABenzinga • 05/18/21
U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung CancerPRNewsWire • 05/18/21
Week In Review: Genscript And Its Legend Bio Subsidiary Raise $1 Billion From HillhouseSeeking Alpha • 05/16/21
Lilly collaborates internationally with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetesPRNewsWire • 05/06/21
Eli Lilly Under FDA Scrutiny At Its COVID-19 Drug Manufacturing Facilities Amid Staff Accusations: ReutersBenzinga • 05/05/21
Lilly plans donation of COVID-19 therapies to Direct Relief for use in low- and lower-middle-income countriesPRNewsWire • 05/04/21
Eli Lilly Donates 400,000 Tablets Of Covid-19 Drug To India, Plans To Scale Up Local ProductionForbes • 05/04/21
Lilly accelerating baricitinib's availability in India following receipt of permission for restricted emergency use as a COVID-19 therapy via donations and licensing agreementsPRNewsWire • 05/04/21
Lilly Declares Second-Quarter 2021 Dividend and Announces Additional Share Repurchase AuthorizationPRNewsWire • 05/03/21